SE0201669D0 - New formulation and use thereof - Google Patents

New formulation and use thereof

Info

Publication number
SE0201669D0
SE0201669D0 SE0201669A SE0201669A SE0201669D0 SE 0201669 D0 SE0201669 D0 SE 0201669D0 SE 0201669 A SE0201669 A SE 0201669A SE 0201669 A SE0201669 A SE 0201669A SE 0201669 D0 SE0201669 D0 SE 0201669D0
Authority
SE
Sweden
Prior art keywords
formulation
administration
nicotine
lungs
essentially
Prior art date
Application number
SE0201669A
Other languages
English (en)
Inventor
Mark P Warchol
Folke Moren
Kristina Thyresson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0201669A priority Critical patent/SE0201669D0/sv
Publication of SE0201669D0 publication Critical patent/SE0201669D0/sv
Priority to TW092114309A priority patent/TW200407142A/zh
Priority to RU2004139067/15A priority patent/RU2283111C2/ru
Priority to NZ536863A priority patent/NZ536863A/en
Priority to AT03756140T priority patent/ATE444753T1/de
Priority to ES03756140T priority patent/ES2332405T3/es
Priority to DK03756140.4T priority patent/DK1509227T3/da
Priority to BR0311451-1A priority patent/BR0311451A/pt
Priority to MXPA04012041A priority patent/MXPA04012041A/es
Priority to PCT/SE2003/000890 priority patent/WO2003101454A1/en
Priority to AU2003243074A priority patent/AU2003243074B2/en
Priority to EP03756140A priority patent/EP1509227B9/en
Priority to DE60329592T priority patent/DE60329592D1/de
Priority to JP2004508811A priority patent/JP4745658B2/ja
Priority to CNB038128098A priority patent/CN100500148C/zh
Priority to CA2487699A priority patent/CA2487699C/en
Priority to ARP030101967A priority patent/AR039947A1/es
Priority to US10/453,808 priority patent/US7767698B2/en
Priority to IL16519504A priority patent/IL165195A0/xx
Priority to ZA200409793A priority patent/ZA200409793B/en
Priority to US12/818,616 priority patent/US8642627B2/en
Priority to JP2010208203A priority patent/JP5430525B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
SE0201669A 2002-06-03 2002-06-03 New formulation and use thereof SE0201669D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE0201669A SE0201669D0 (sv) 2002-06-03 2002-06-03 New formulation and use thereof
TW092114309A TW200407142A (en) 2002-06-03 2003-05-27 New formulation and use thereof
CA2487699A CA2487699C (en) 2002-06-03 2003-05-30 A buffered, liquid nicotine composition for pulmonary administration
AU2003243074A AU2003243074B2 (en) 2002-06-03 2003-05-30 A buffered, liquid nicotine composition for pulmonary administration
EP03756140A EP1509227B9 (en) 2002-06-03 2003-05-30 A buffered, liquid nicotine composition for pulmonary administration
AT03756140T ATE444753T1 (de) 2002-06-03 2003-05-30 Gepufferte flüssige nikotinzusammensetzung zur pulmonalen verabreichung
ES03756140T ES2332405T3 (es) 2002-06-03 2003-05-30 Una composicion de nicotina liquida tamponada para administracion pulmonar.
DK03756140.4T DK1509227T3 (da) 2002-06-03 2003-05-30 En bufferet, flydende nikotinsammensætning til pulmonal indgivelse
BR0311451-1A BR0311451A (pt) 2002-06-03 2003-05-30 Composição tamponada de nicotina lìquida para administração pulmonar
MXPA04012041A MXPA04012041A (es) 2002-06-03 2003-05-30 Una composicion liquida y regulada de nicotina para administracion pulmonar.
PCT/SE2003/000890 WO2003101454A1 (en) 2002-06-03 2003-05-30 A buffered, liquid nicotine composition for pulmonary administration
RU2004139067/15A RU2283111C2 (ru) 2002-06-03 2003-05-30 Забуференная жидкая никотиновая композиция для легочного введения
NZ536863A NZ536863A (en) 2002-06-03 2003-05-30 A buffered, liquid nicotine composition comprising a nicotine salt
DE60329592T DE60329592D1 (de) 2002-06-03 2003-05-30 Gepufferte flüssige nikotinzusammensetzung zur pulmonalen verabreichung
JP2004508811A JP4745658B2 (ja) 2002-06-03 2003-05-30 肺投与のための緩衝化液状ニコチン組成物
CNB038128098A CN100500148C (zh) 2002-06-03 2003-05-30 用于肺部施用的缓冲液体烟碱组合物
US10/453,808 US7767698B2 (en) 2002-06-03 2003-06-02 Formulation and use thereof
ARP030101967A AR039947A1 (es) 2002-06-03 2003-06-02 Formulacion farmaceutica que comprende nicotina
IL16519504A IL165195A0 (en) 2002-06-03 2004-11-14 A buffered, liquid nicotine composition for pulmonary administration
ZA200409793A ZA200409793B (en) 2002-06-03 2004-12-02 A buffered, liquid nicotine composition for pulmonary administration
US12/818,616 US8642627B2 (en) 2002-06-03 2010-06-18 Formulation and use thereof
JP2010208203A JP5430525B2 (ja) 2002-06-03 2010-09-16 肺投与のための緩衝化液状ニコチン組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201669A SE0201669D0 (sv) 2002-06-03 2002-06-03 New formulation and use thereof

Publications (1)

Publication Number Publication Date
SE0201669D0 true SE0201669D0 (sv) 2002-06-03

Family

ID=20288046

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201669A SE0201669D0 (sv) 2002-06-03 2002-06-03 New formulation and use thereof

Country Status (19)

Country Link
EP (1) EP1509227B9 (sv)
JP (2) JP4745658B2 (sv)
CN (1) CN100500148C (sv)
AR (1) AR039947A1 (sv)
AT (1) ATE444753T1 (sv)
AU (1) AU2003243074B2 (sv)
BR (1) BR0311451A (sv)
CA (1) CA2487699C (sv)
DE (1) DE60329592D1 (sv)
DK (1) DK1509227T3 (sv)
ES (1) ES2332405T3 (sv)
IL (1) IL165195A0 (sv)
MX (1) MXPA04012041A (sv)
NZ (1) NZ536863A (sv)
RU (1) RU2283111C2 (sv)
SE (1) SE0201669D0 (sv)
TW (1) TW200407142A (sv)
WO (1) WO2003101454A1 (sv)
ZA (1) ZA200409793B (sv)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
DK3473251T3 (da) 2002-12-20 2024-01-22 Niconovum Ab Nikotin-cellulose-kombination
CN100381083C (zh) 2003-04-29 2008-04-16 韩力 一种非可燃性电子喷雾香烟
CN2719043Y (zh) 2004-04-14 2005-08-24 韩力 雾化电子烟
EP2532650A3 (en) 2004-06-24 2013-11-06 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US20160345631A1 (en) 2005-07-19 2016-12-01 James Monsees Portable devices for generating an inhalable vapor
PL3219705T3 (pl) 2005-12-28 2020-08-10 Vertex Pharmaceuticals Incorporated Kompozycje farmaceutyczne amorficznych postaci n-[2,4-bis(1,1-dimetyloetylo)-5-hydroksyfenylo]-1,4-dihydro-4-oksochinolino-3-karboksyamidu
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
CN201067079Y (zh) 2006-05-16 2008-06-04 韩力 仿真气溶胶吸入器
RU2010114732A (ru) * 2007-09-14 2011-10-20 Вертекс Фармасьютикалз Инкорпорейтед (Us) Твердые формы n-[2,4-бис(1,1-диметилэтил)-5-гидроксифенил]-1,4-дигидро-4-оксохинолин-3-карбоксамида
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
CN201379072Y (zh) 2009-02-11 2010-01-13 韩力 一种改进的雾化电子烟
US8476442B2 (en) 2009-03-20 2013-07-02 Vertex Pharmaceutical Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
MY163517A (en) * 2009-09-16 2017-09-15 Philip Morris Products Sa Improved device and method for delivery of a medicament
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
WO2012106739A1 (de) 2011-02-11 2012-08-16 Helmut Buchberger Inhalatorkomponente
US9399110B2 (en) 2011-03-09 2016-07-26 Chong Corporation Medicant delivery system
US8903228B2 (en) 2011-03-09 2014-12-02 Chong Corporation Vapor delivery devices and methods
BR112013022757A2 (pt) 2011-03-09 2021-01-05 Chong Corporation Sistema de entrega de medicamento
BR112014004818B1 (pt) 2011-09-06 2021-01-05 British American Tobacco (Investments) Limited. aparelho para aquecer material fumável e método para aquecer material fumável
PL2753202T3 (pl) 2011-09-06 2016-11-30 Podgrzewanie materiału przeznaczonego do palenia
AT511344B1 (de) 2011-10-21 2012-11-15 Helmut Dr Buchberger Inhalatorkomponente
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
RU2692779C2 (ru) 2012-02-27 2019-06-27 Вертекс Фармасьютикалз Инкорпорейтед Фармацевтическая композиция и ее введения
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2504076A (en) 2012-07-16 2014-01-22 Nicoventures Holdings Ltd Electronic smoking device
GB201215282D0 (en) 2012-08-28 2012-10-10 Kind Consumer Ltd An inhaler
GB201215273D0 (en) 2012-08-28 2012-10-10 Kind Consumer Ltd Nicotine composition
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US10638792B2 (en) 2013-03-15 2020-05-05 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
GB2513637A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
GB2513639A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
CN105263345A (zh) * 2013-05-06 2016-01-20 派克斯实验公司 用于气溶胶装置的烟碱盐调配物及其方法
GB2514893B (en) 2013-06-04 2017-12-06 Nicoventures Holdings Ltd Container
US10251422B2 (en) 2013-07-22 2019-04-09 Altria Client Services Llc Electronic smoking article
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
DE202014011221U1 (de) 2013-12-23 2018-09-13 Juul Labs Uk Holdco Limited Systeme für eine Verdampfungsvorrichtung
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
US9896429B2 (en) 2014-05-27 2018-02-20 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
CN113754634A (zh) * 2014-05-27 2021-12-07 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体络合物
GB2528673B (en) 2014-07-25 2020-07-01 Nicoventures Holdings Ltd Aerosol provision system
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶
GB2535427A (en) 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
GB2532062A (en) * 2014-11-07 2016-05-11 Nicoventures Holdings Ltd Container
AU2015357509B2 (en) 2014-12-05 2021-05-20 Juul Labs, Inc. Calibrated dose control
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
CN114656446A (zh) * 2015-11-25 2022-06-24 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体配合物
US9867397B2 (en) 2016-01-11 2018-01-16 Patrick Beymer Nicotine delivery system
WO2017139595A1 (en) 2016-02-11 2017-08-17 Pax Labs, Inc. Fillable vaporizer cartridge and method of filling
CA3015306A1 (en) * 2016-02-29 2017-09-08 Nicogen Ltd. Nicotine formulation and aerosols
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
CA3103090C (en) 2016-04-27 2023-03-28 Nicoventures Trading Limited Electronic aerosol provision system and vaporizer therefor
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
US20200315241A1 (en) * 2017-06-26 2020-10-08 Nude Nicotine, Inc. Nicotine Salts and Methods of Making and Using Same
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery
GB201817864D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
WO2021123871A1 (en) 2019-12-15 2021-06-24 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
WO2021123869A1 (en) 2019-12-15 2021-06-24 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
JP2023506330A (ja) 2019-12-15 2023-02-15 シャヒーン イノベーションズ ホールディング リミテッド 超音波ミスト吸入器
SI3837999T1 (sl) 2019-12-15 2022-10-28 Shaheen Innovations Holding Limited Naprave za inhaliranje meglic
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030862A (en) * 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
GB9200047D0 (en) * 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray

Also Published As

Publication number Publication date
NZ536863A (en) 2007-05-31
RU2283111C2 (ru) 2006-09-10
MXPA04012041A (es) 2005-08-16
RU2004139067A (ru) 2005-08-10
ZA200409793B (en) 2006-08-30
BR0311451A (pt) 2005-03-15
DK1509227T3 (da) 2010-02-01
CN100500148C (zh) 2009-06-17
JP5430525B2 (ja) 2014-03-05
AU2003243074A1 (en) 2003-12-19
WO2003101454A1 (en) 2003-12-11
CA2487699C (en) 2012-04-17
ATE444753T1 (de) 2009-10-15
JP4745658B2 (ja) 2011-08-10
ES2332405T3 (es) 2010-02-04
EP1509227B9 (en) 2010-05-19
AU2003243074B2 (en) 2008-11-20
JP2010280721A (ja) 2010-12-16
IL165195A0 (en) 2005-12-18
DE60329592D1 (de) 2009-11-19
CA2487699A1 (en) 2003-12-11
AR039947A1 (es) 2005-03-09
EP1509227A1 (en) 2005-03-02
CN1658876A (zh) 2005-08-24
TW200407142A (en) 2004-05-16
EP1509227B1 (en) 2009-10-07
JP2005533770A (ja) 2005-11-10

Similar Documents

Publication Publication Date Title
SE0201669D0 (sv) New formulation and use thereof
SE0104388D0 (sv) New formulation and use and manufacture thereof
SE0102276D0 (sv) Device and method for the administration of a medicament
BRPI0515932A (pt) composições e métodos para distribuição intranasal, bucal, sublingual e pulmonar de vareniclina
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
NO20063373L (no) CD40-antistoff-formuleringer og fremgangsmater
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
RS20090105A (en) Medicament compositions based on tiotropium salts and on salmetrol salts
HK1098960A1 (en) Method and composition for treating rhinitis
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
GB0323684D0 (en) Improvements in or relating to organic compounds
DK1343472T3 (da) Thixotropisk næsespray
TW200501934A (en) Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
MY135460A (en) Method of stimulating hair growth using benzopyrans
CY1109215T1 (el) Συστημα χορηγησης οπιοειδους
ATE452639T1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen
BR0316123A (pt) Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico
ATE340576T1 (de) Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation
BRPI0418582A (pt) sistema de administração de opióides
KR20060115092A (ko) 니코틴을 함유하는 구강청정제